+12.0%
GSK vs PENG
+103.2%
-91.2%
-22.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | PENG | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.6% | -2.3% | +1.7% | -0.7% |
| 7D | +5.2% | -16.1% | +21.3% | +4.6% |
| 30D | +10.2% | -41.5% | +51.7% | +8.6% |
| 3M | -0.9% | -19.1% | +18.2% | -1.5% |
| 6M | +3.5% | +0.9% | +2.6% | +1.5% |
| YTD | +7.2% | +128.2% | -121.0% | -0.5% |
| 1Y | +12.0% | +98.6% | -86.6% | +4.6% |
| All | +12.0% | +103.2% | -91.2% | +4.6% |
Cumulative growth
Daily Returns
Daily percentage return beside PENG.
Daily Out/Under-Performance
Portfolio return minus PENG return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × PENG return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded PENG wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling